• 研究概要
• 略歴
• 論文

研究概要

Historical perspectives on biological sciences and their applications

Scientific breakthroughs and technological innovations often seem to erupt on the scene, posing urgent social, regulatory, ethical and economic challenges. As a correspondent for Nature, Cyranoski spent two decades covering such critical interactions between science and society, notably in controversial areas such as stem cells and reproductive biology.

But scientific discoveries have long trajectories, and understanding how they emerged will help us grapple with their implications. Cyranoski is now examining the recent history of stem cells, reproductive biology, developmental biology and other research fields in order to describe and understand how social factors shaped their evolution, how underlying scientific uncertainty affects their development, and how regulatory decision-making has guided their clinical translation. His analyses will also take into account other factors, such as the impact of commercial interests and the role of public engagement by scientists trying to earn acceptance of their findings. The results of such studies will differ depending on the technology, vary by setting, and change over time, offering a rich array of contexts to analyze for insights into how science evolves and how we can best come to grips with the latest scientific trends.

略歴

David Cyranoski earned a master’s degree and passed the doctoral exam in the History of Science and the History of Japan at the University of California-Berkeley. From 2000, based first in Japan and then in China, he spent more than 20 years as the Asia-Pacific Correspondent for Nature covering the gamut of biological and physical sciences at the cutting-edge. He joined ASHBi in 2021.

論文

Cyranoski, D., Sipp, D., Mallik, S., and Rasko, J.E.J. (2023). Too little, too soon: Japan’s experiment in regenerative medicine deregulation. Cell Stem Cell 30, 913–916.

Cyranoski, D. (2023). Opinion Guest Essay: How a scientific fraud reinvented himself. The New York Times. June 21, 2023.

Cyranoski, D., Contreras, J.L., and Carrington, V.T. (2023). Intellectual property and assisted reproductive technology. Nat. Biotechnol. 41, 14–20.

Cyranoski, D., Contreras, J.L., and Carrington, V.T. (2023) Who will own the next generation of assisted reproductive technologies? Nature Portfolio Bioengineering Community https://bioengineeringcommunity.nature.com/posts/who-will-own-the-next-generation-of-assisted-reproductive-technologies. (Blog post)

Cyranoski, D. (2021). AI drug discovery booms in China. Nat. Biotechnol. 39, 900–902.